Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45


Immunity, inflammation, and cancer.

Grivennikov SI, Greten FR, Karin M.

Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025. Review.


Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.

Huang L, Muthuswamy SK.

Curr Opin Genet Dev. 2010 Feb;20(1):41-50. doi: 10.1016/j.gde.2009.12.001. Epub 2010 Jan 21. Review.


Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity.

Nelson WJ.

Cold Spring Harb Perspect Biol. 2009 Jul;1(1):a000513. doi: 10.1101/cshperspect.a000513. Review.


TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect.

Joshi A, Cao D.

Front Biosci (Landmark Ed). 2010 Jan 1;15:180-94. Review.


Epithelial-mesenchymal transitions in development and disease.

Thiery JP, Acloque H, Huang RY, Nieto MA.

Cell. 2009 Nov 25;139(5):871-90. doi: 10.1016/j.cell.2009.11.007. Review.


Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis.

Reischauer S, Levesque MP, Nüsslein-Volhard C, Sonawane M.

PLoS Genet. 2009 Nov;5(11):e1000720. doi: 10.1371/journal.pgen.1000720. Epub 2009 Nov 13.


Localization of nectin-free afadin at the leading edge and its involvement in directional cell movement induced by platelet-derived growth factor.

Miyata M, Ogita H, Komura H, Nakata S, Okamoto R, Ozaki M, Majima T, Matsuzawa N, Kawano S, Minami A, Waseda M, Fujita N, Mizutani K, Rikitake Y, Takai Y.

J Cell Sci. 2009 Dec 1;122(Pt 23):4319-29. doi: 10.1242/jcs.048439. Epub 2009 Nov 3.


Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.

Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM.

Genes Dev. 2009 Sep 15;23(18):2140-51. doi: 10.1101/gad.1820209.


14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition.

Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, Feng X, Seewaldt VL, Muller WJ, Sahin A, Hung MC, Yu D.

Cancer Cell. 2009 Sep 8;16(3):195-207. doi: 10.1016/j.ccr.2009.08.010.


Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB.

Cancer Res. 2009 May 15;69(10):4116-24. doi: 10.1158/0008-5472.CAN-08-3441. Epub 2009 May 12.


Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.

Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Wistuba II, Lozano G, Kurie JM.

PLoS One. 2009;4(4):e5401. doi: 10.1371/journal.pone.0005401. Epub 2009 Apr 30.


Microenvironmental regulation of metastasis.

Joyce JA, Pollard JW.

Nat Rev Cancer. 2009 Apr;9(4):239-52. doi: 10.1038/nrc2618. Epub 2008 Mar 12. Review.


Modelling oncogenic Ras/Raf signalling in the mouse.

Karreth FA, Tuveson DA.

Curr Opin Genet Dev. 2009 Feb;19(1):4-11. doi: 10.1016/j.gde.2008.12.006. Epub 2009 Feb 7. Review.


Polarity and differential inheritance--universal attributes of life?

Macara IG, Mili S.

Cell. 2008 Nov 28;135(5):801-12. doi: 10.1016/j.cell.2008.11.006. Review.


Polarity proteins in migration and invasion.

Etienne-Manneville S.

Oncogene. 2008 Nov 24;27(55):6970-80. doi: 10.1038/onc.2008.347. Review.


Cancer-related inflammation.

Mantovani A, Allavena P, Sica A, Balkwill F.

Nature. 2008 Jul 24;454(7203):436-44. doi: 10.1038/nature07205. Review.


Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling.

Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO.

Oncogene. 2008 Oct 9;27(46):5988-6001. doi: 10.1038/onc.2008.219. Epub 2008 Jul 21.


Macrophages define the invasive microenvironment in breast cancer.

Pollard JW.

J Leukoc Biol. 2008 Sep;84(3):623-30. doi: 10.1189/jlb.1107762. Epub 2008 May 8. Review.


Cell polarity and cancer--cell and tissue polarity as a non-canonical tumor suppressor.

Lee M, Vasioukhin V.

J Cell Sci. 2008 Apr 15;121(Pt 8):1141-50. doi: 10.1242/jcs.016634.


Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

Supplemental Content

Support Center